Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/AYALA PHARMACEUTICALS INC/ 8-K/A

Current Report · 8-K/A

AYALA PHARMACEUTICALS INC

ADXSNASDAQEQUITYCurrent

Current Report

Filed Apr 19, 2024Accepted Apr 19, 2024, 3:50 AM EDTCIK 1100397Accession 0000929638-24-001532
View company →Permanent SEC source ↗
Share

Company context

Current securities

ADXSNASDAQ · EQUITY · Current
Historical securities (1)
ADXSWNASDAQ · WARRANT · Historical · closed Oct 19, 2018

Recent company filings

  1. SCHEDULE 13G - filed by Ayala Pharmaceuticals, Inc. regarding OS Therapies IncApr 16, 2025
  2. 15-12G filingMay 9, 2024
  3. 10-K/A filingApr 26, 2024
  4. 10-K filingApr 16, 2024
  5. S-8 POS filingApr 15, 2024